Latest Blog Posts from Bioenergy


Pyrofab is coming to Saarland

An innovative, mobile energy-from-waste technology demonstrator will be coming to Saarland this month on the opening leg of a tour of North West Europe. On the 24th July IZES gGmbH and our local partner Evontec GmbH will be welcoming Ms. Astrid Klug from the Saarland Ministry of Energy to mark the arrival of the ‘Pyrofab’ in the city of Ottweiler-Fürth. The event will be open to the BioenNW partner consortium, regional companies and environmental service providers, politicians, authorities and members of the IZES Bioenergy network.

What is the Pyrofab

The Pyrofab is a demonstration technology for intermediate pyrolysis, developed through the BioenNW partnership at the European Bioenergy Research Institute (EBRI) at Aston University in Birmingham, UK and begins its European tour in Saarland. The Pyrofab tour will visit five locations around Europe hosted by BioenNW partners. The Pyrofab can demonstrate the intermediate pyrolysis process and will be performing cold run tests from the 24th July.

Why is the Pyrofab different to other technologies?

The Pyrofab is based on unique Pyroformer™ intermediate pyrolysis technology. Its double screw system can process a wide range of different organic waste and residues. Therefore it is an approach to show that even hard to treat sources of waste now have the potential to be used as a feedstock to produce low-carbon energy in from of oil and coal. Feedstocks being tested include food waste, domestic waste, agricultural waste such as pig manure, industrial waste and even baby wipes. Pyrofab is also compact and portable, allowing fuel to be locally sourced to reduce reliance on imports of fuel and biomass, reduce the impact of waste transportation and stimulate regional economies.

What are the potential benefits of the Pyrofab for government and businesses?

If the tests are successful and the Pyrofab is fully developed, it may offer businesses access to the emerging bioenergy market, mainly situated in rural areas. 2014, the overall bioenergy market in Germany alone was worth €12 Billion, recently growing in the residues sector in the next years. The demand on bioenergy is expected to increase due to its functions as a flexible fuel in the energy system. The low CO2 abatement costs in combination with a strong emission trading system as well as the variety of ways in which the pyrolysis products can be used, imply a huge economic potential of this technology.

Words by Michael Porzig
IZES gGmbH, Germany

For more information about the Pyrofab in Germany and its European tour please visit:

IZES gGmbH website:

IZES gGmbH Twitter:

IZES gGmbH LinkedIn:

IZES gGmbH Facebook: